إعلان
إعلان

ZURA

ZURA logo

Zura Bio Limited Class A Ordinary Shares

5.12
USD
برعاية
-0.14
-2.66%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

5.12

0.00
0.00%

تقارير أرباح ZURA

النسبة الإيجابية المفاجئة

ZURA تفوق 5 من 10 آخر التقديرات.

50%

التقرير التالي

بيانات التقرير القادم
٢٣ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.20
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
-4.76%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
+100.00%

Zura Bio Limited Class A Ordinary Shares earnings per share and revenue

On ١٣ نوفمبر ٢٠٢٥, ZURA reported earnings of -0.21 USD per share (EPS) for Q3 25, missing the estimate of -0.18 USD, resulting in a -13.45% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -9.72% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 المحللين forecast an EPS of -0.20 USD, with revenue projected to reach -- USD, implying an نقصان of -4.76% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Zura Bio Limited Class A Ordinary Shares reported EPS of -$0.21, missing estimates by -13.45%, and revenue of $0.00, 0% as expectations.
The stock price moved down -9.72%, changed from $4.63 before the earnings release to $4.18 the day after.
The next earning report is scheduled for ٢٣ مارس ٢٠٢٦.
Based on 9 المحللين, Zura Bio Limited Class A Ordinary Shares is expected to report EPS of -$0.20 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان